American Portfolios Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
N
American Portfolios Advisors's ALNY Position: Q3 2022 in Review
American Portfolios Advisors opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2022: 30 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #2746 among its holdings. This is a return to the name: American Portfolios Advisors previously reported a position in ALNY as recently as Q2 2020.
American Portfolios Advisors first reported a position in ALNY in Q2 2020 and has held it in 2 quarters since. The position peaked at $531K in Q2 2020. 496 funds tracked by Wall St. Rank hold ALNY as of Q3 2022.
- American Portfolios Advisors held 30 shares of Alnylam Pharmaceuticals worth $6K as of Q3 2022.
- Alnylam Pharmaceuticals was a new American Portfolios Advisors position in Q3 2022.
- Alnylam Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2746 holding.
- American Portfolios Advisors first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 2 quarters since.
- American Portfolios Advisors's Alnylam Pharmaceuticals position peaked at $531K in Q2 2020.
- 496 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.